Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 55357-38-5 | MDL No. : | MFCD00079051 |
Formula : | C12H21NO4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DVGVMQVOCJNXNJ-UHFFFAOYSA-M |
M.W : | 275.36 | Pubchem ID : | 10923804 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 69.1 |
TPSA : | 85.81 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.55 cm/s |
Log Po/w (iLOGP) : | -1.34 |
Log Po/w (XLOGP3) : | 0.6 |
Log Po/w (WLOGP) : | 1.66 |
Log Po/w (MLOGP) : | -2.39 |
Log Po/w (SILICOS-IT) : | -0.57 |
Consensus Log Po/w : | -0.41 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.97 |
Solubility : | 2.92 mg/ml ; 0.0106 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.98 |
Solubility : | 2.91 mg/ml ; 0.0106 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.26 |
Solubility : | 15.2 mg/ml ; 0.0551 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.24 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | at 20℃; for 24 h; | 22.3 g (250 mmol) of dimethylaminoethanol and 1 L of THF were placed in a four-necked flask (2 L), and the mixture was stirred at room temperature. 250 mL of a THF solution of 51.2 g (275 mol) of methyl tosylate was added dropwise and the mixture was stirred at room temperature for 24 hours. THF was distilled off, and the desired product was purified by recrystallization with 1 L of acetone. Colorless solid Yield 95percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
59% | (R) -1,2-glyceryl distearate-glycerol-3-phosphatidic acid (0.2 g, 0.28 mmol)Was added to 60 mL of dry pyridine,It was heated at 50 0.5h,Then, <strong>[55357-38-5]choline p-toluenesulfonate</strong> (0.84 g, 3 mmol)And trichloroacetonitrile 5mL,The reaction was continued at 50 36h,Concentration under reduced pressure crude,Flash column chromatography (developing solvent CHCl3-CH3OH-H2O, 15: 5: 1) gave a white gel, 0.13 g, 59% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | In tetrahydrofuran; at 20℃; for 24h; | 22.3 g (250 mmol) of dimethylaminoethanol and 1 L of THF were placed in a four-necked flask (2 L), and the mixture was stirred at room temperature. 250 mL of a THF solution of 51.2 g (275 mol) of methyl tosylate was added dropwise and the mixture was stirred at room temperature for 24 hours. THF was distilled off, and the desired product was purified by recrystallization with 1 L of acetone. Colorless solid Yield 95%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; In trichloroacetonitrile; at 50℃; for 76h; | 40 mg of {2-[(4'-Hexyl-biphenyl-4-carbonyl)-amino]-benzyl}-phosphonic acid (compound of preparation example 3) are dissolved in 10 ml of pyridine and 111 mg of dry choline p- toluolsulfonate salt and 2 ml trichloroacetonitrile are added. The mixture obtained is stirred at 500C for 76 hours. From the mixture obtained solvent is evaporated and the evaporation residue is subjected to RP-18 chromatography (0,1% TFA-water/methanol gradient). [2-({2- [(4'-Hexyl-biphenyl-4-carbonyl)-amino]-be?zyl}-hydroxy-phosphinoyloxy)-ethyl]-trimethyl- ammonium, inner salt is obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; at 55℃; for 4h; | P1-(cytidin-5'-yl)-P2-(trimethylammoniumethyl)-methylenebis(phosphonate) is an analog of cytidyl diphosphocholine (citicholine), an important intermediate in lipid metabolism and a drug under development for treatment for ischemic stroke. The analog may be prepared by the reaction of the appropriate BTA with a p-toluenosulfonate salt of choline. Thus, a mixture of the BTA prepared from N4-acetylcytidin-5'-ylphosphonomethylenephosphonic acid (1 mmol in 10 ml of dry pyridine) and p-toluenosulfonate salt of choline (412 mg, 1.5 mmol) is kept at 55C for 4 hours. The mixture is processed as described in Example 3. P1-(N4-acetyl-2',3'-O-isopropylidenecytidin-5'-yl)-P2-(trimethylammoniumethyl)-methylenebisphosphonate is obtained, and deprotected with Dowex 50WX8/H+ to give the desired compound. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23% | To a solution comprising compound la prepared starting from 7.4 gr. of compound 2a a solution of 12.7 gr. of <strong>[55357-38-5]choline tosylate</strong> in dry acetonitrile was added. A solution of 5.9 ml. of triethylamine in 4 ml. DCM was added thereto. The reaction mixture was stirred overnight. The reaction mixture was then concentrated, 250 ml. of hexane was added and evaporated to dryness. The residue was redissolved in 390 ml. of THF and precipitated <strong>[55357-38-5]choline tosylate</strong> was filtered. Concentrated HCl (1. 7ml) was added and the reaction mixture was stirred for 1 hour. The reaction mixture was dried over magnesium sulfate, filtered, and the pH was basified with triethylamine. The precipitation was filtered, the filtrate was evaporated to dryness and then redissolved in a solvent mixture consisting of chloroform, methanol and water (8: 4: 3). The lower phase was separated and washed 4 times with the same upper phase and evaporated. The crude product was dissolved in 45 ml. of 1M tetrabutylammonium fluoride in THF and the reaction mixture was stirred at 45C for 2 hours. The resulting solution was evaporated and the crude product was purified by silicagel chromatographic column. (Eluent: gradual mounting concentration of methanol in chloroform). The relevant fractions were evaporated and the resulting product was then co-evaporated with acetonitrile. 1.49 of pure product was obtained (23% yield). 1H NMR 300 MHz (8 ppm, CD30D) : 0.92 (t, 3H), 1.31 (bm, 20H), 1.44 (m, 2H), 2.10 (q, 2H), 2.92 (m, 1H), 3. 33 (m, 1H), 3.67 (m, 2H), 3.92 (m, 1H), 4.04 (m, 2H), 4.30 (m, 2H), 5.55 (dd, 1H), 5. 78 (dt, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; sodium hydrogencarbonate; trichlorophosphate; In quinoline; chloroform methanol; dichloromethane; water; acetone; | EXAMPLE 1 A solution of 48.7 g of cholest-5-en-3beta-yl 2-hydroxyethylcarbonate and 10 ml of quinoline in 500 ml of methylene chloride is added dropwise at room temperature to a solution of 12.5 ml of phosphorus oxychloride. The solution is treated at room temperature while stirring with 60 ml of pyridine and 77 g of <strong>[55357-38-5]choline tosylate</strong> in 500 ml of methylene chloride, whereupon the reaction mixture is stirred at room temperature overnight. The mixture is treated with 125 ml of water and 34 g of sodium bicarbonate and then with 3000 ml of acetone. The precipitated product is filtered off under suction, dissolved in 1000 ml of chloroform-methanol 1:1 and stirred with 500 g of ion exchanger (Amberlite MB-3). The latter is filtered off under suction and the solution is evaporated. The resulting residue is recrystallized in a mixture of methylene chloride-methanol 1:1 and dioxan. There are obtained 39 g of O-[[2-[[(cholest-5-en-3beta-yloxy)carbonyl]oxy]ethoxy]hydroxyphosphinyl]choline hydroxide internal salt of melting point 224 C., MS: 640 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium hydrogencarbonate; trichlorophosphate; In tetrahydrofuran; pyridine; methanol; chloroform; | EXAMPLE 9 A solution of 2.22 g of (E)-stigmasta-5,22-dien-3beta-yl (2-hydroxyethyl)carbonate and 1.1 ml of pyridine in 10 ml of chloroform is added dropwise to a solution, cooled to 0 C., of 0.75 g of phosphorus oxychloride in 3 ml of chloroform. The mixture is reacted at room temperature for 1 hour. Then, 1.6 g of <strong>[55357-38-5]choline tosylate</strong> in 15 ml of pyridine are added. The mixture is stirred overnight, then a solution of 2 g of potassium bicarbonate is added. The mixture is evaporated to dryness and the residue is taken up in 100 ml of THF/methanol/chloroform (1/1/1). The solids are filtered off. The solution remaining behind is percolated over an ion exchanger (Amberlite MB-3). After chromatography on silica gel with chloroform/methanol/water (60/35/5 vol) and crystallization from methylene chloride/acetone there are obtained 1.6 g of O-[hydroxy-[2-[[[(E)-stigmasta-5,22-dien-3beta-yloxy]carbonyl]oxy]ethoxy]phosphinyl]choline hydroxide internal salt, MS: 666 (M+H+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | Fig. 2. Synthesis of the novel phospholipid analogs 1-O-DPPC and 1-O-DPPG' with the phosphate in the C-2 position from (S)-O-benzyl glycidol. (a) C16H33OH,NaH, DMF/THF (71%); (b) i. POCl3, Et3N, DCM, ii. Pyridine, <strong>[55357-38-5]Choline tosylate</strong> EPO <DP n="7"/>(65%); (c) H2, Pd/C, MeOH (99%); (d) C15H31COOH, DMAP, Et3N, DCM (83%); (e) (1-Pr)2NP(OMe)Cl, TMP, DCM; (f) i. (R)-isopropylidene glycerol, Phenyl- IH- tetrazole, DCM, ii. t-BuOOH (67% over 2 steps); (g) H2, Pd/C, MeOH (99%); (h) Palmitic acid, DMAP, DCC, DCM (92%); (i) i. CH3CN, isopropanol, Me3N, DCM, ii. HCl, MeOH, DCM, H2O, iii. NaHCO3, DCM (70%).; The unnatural PC and PG phospholipids (1-O-DPPC, 1-O-DPPG') with the phos- phocholine and phosphoglycerol head groups linked to the C-2 position of the glyc¬ erol moiety were synthesized utilizing (S)-O-benzyl glycidol as a versatile starting material [27,28] as shown in Fig. 2. Opening of the epoxide 1 under basic condi¬ tions, using THF/DMF (1:1) as a solvent system that minimizes dimerization gave 2 in 71% yield after purification by column chromatography. The phosphorylation was performed using phosphorous oxychloride in CH2Cl2 [27], which gave 3 in 65% yield. Debenzylation under H2 atmosphere with Pd/C as catalyst followed by a sim¬ ple acylation using palmitoyl chloride gave the target 1-O-DPPC lipid. The synthe¬ sis of 1-O-DPPG' was carried out from 2 using (1-Pr)2NPClOMe [31] as the phos- phorylation reagent. The phosphorylation using TMP as base in the lipid coupling followed by (R)-isopropylidene glycerol with 5-phenyl-lH-tetrazole as a weak pro¬ ton donor gave the protected phospholipid 4 in 67% yield after oxidation. Debenzy¬ lation followed by acylation using DCC gave 5 in 92% yield. Deprotection of lipid 5 was carried out with Me3N to remove the methyl protection group, followed by stir- ring in CH2Cl2/MeOH/0.5M HCl (65:25:4) resulting in removal of the isopro- pylidene group. Finally, the proton on the phosphate was exchanged with sodium us- EPO <DP n="51"/>ing NaHCO3, which gave the desired 1-O-DPPG' in 70% yield after purification by column chromatography. AEL-43 and AEL-44 were obtained by simple deprotec- tion. Debenzylation of 3 under H2 with Pd/C as catalyst gave AEL-43 in quantitative yield. Deprotection of 4 was carried out using Me3N, CH2Cl2/MeOH/0.5M HCl (65:25:4) as described above followed by debenzylation using H2-PdZC which gave AEL-44 in 71% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
120 g (61%) | With pyridine; In tetrahydrofuran; water; acetonitrile; | (ii) 2-Trimethylammonioethyl cetyl phosphonate Cetyl phosphonate (153 mg) and <strong>[55357-38-5]choline tosylate</strong> (0.5 g) are added to 4 ml of pyridine. The mixture was dissolved by heating at 50 C. To this solution was added trichloroacetonitrile (2 ml). The mixture was heated at 50 C. for 50 hours. One half volume of pyridine was evaporated off under reduced pressure. To the residue was added under stirring acetonitrile (20 ml). The resulting precipitates were collected to yield colorless powder (160 mg). The powder was dissolved in a mixture of tetrahydrofuran and water (7:3). The solution was poured onto a mixed resin (3 ml) of IRA410-Dowex 50W (2:1). The fractional elude was concentrated to dryness under reduced pressure. The residue was subjected to a silica-gel (10 g) column chromatography using chloroform-methanol-water [65:25:4 (by volume)] as the eluent. The fractional eluates were collected and concentrated to dryness. The residue was recrystallized from chloroform-acetone to give 120 g (61%) of colorless needles. IR(KBr)cm-1: 2910(CH), 2850(CH), 1465(CH2), 1200(P=O), 1190(P=O), 1077, 1045, 960. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With trichloroacetonitrile; In pyridine; at 50℃; for 48h; | Preparation of 2'-(trimethylammonio)ethyl 4-hexadecyloxy-3(S)-Lambda/- methylcarbamoyl-1-butane-phosphonate (Compound II). To a solution of 512 mg (1.07 mmol) of carbamoyl phosphonate 7 in 25 mL of CH2CI2 was added 500 muL (3.79 mmol) of trimethylsily. bromide. After the mixture was allowed to stand overnight at room temperature, the volatile materials were removed under reduced pressure to give a residue. To the residue was added 1.45 g (3.01 mmol) of <strong>[55357-38-5]choline tosylate</strong>, and the mixture was dried overnight under high vacuum. After the dry mixture was dissolved in 50 mL of pyridine, 1.5 mL (15.0 mmol) of trichloroacetonitrile was added, and the reaction mixture was heated for 48 h at 500C (oil bath temperature). On removal of most of the pyridine by rotary evaporation, a brown residue was formed, which was dissolved in THF/H2O (10 mL, 9:1 v/v) and passed through a column of TMD-8 resin (previously equilibrated with the same solvent mixture). The product was purified by silica gel chromatography (elution with CHCl3/MeOH/H2O 65:25:4 v/v/v). The fractions containing the product (as identified by TLC) were pooled and concentrated under reduced pressure. The residue was dissolved in CHCI3 (15-25 mL) and passed through a Cameo filter three times to remove the suspended silica gel. The filtrate was concentrated to give a residue, which was lyophilized from benzene to afford 395 mg (69%) of phosphonate 1a as a white powder; [alpha]25D -2.53 (c 0.21 , CHCI3/MeOH 1:1); 1H NMR (CDCI3/CD3OD) delta 0.89 (t, 3H, J = 6.4 Hz), 1.26 (br s, 26H), 1.32-1.35 (m, 2H), 1.44-1.62 (m, 4H), 1.86-1.95 (m, 2H), 2.86 (d, 3H, J = 4.8 Hz), 3.24 (s, 9H), 3.30-3.70 (m, 8H), 4.90-5.00 (m, 1H); 13C NMR (CDCI3) delta 14.1, EPO <DP n="19"/>20.7 (d, J = 143 Hz), 22.6, 25.1 (d, J = 4.1 Hz), 26.0, 26.1, 26.4, 29.3, 29.4, 29.5, 29.6, 31.9, 56.5 (d, J = 4.7 Hz), 65.8, 70.6 (d, J = 5.8 Hz), 75.4, 75.5, 74.9, 153.7; MS (electrospray) M+ m/z calcd for C27H58N2O6P 537.37, found 537.4. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31% | To the solution comprising compound la a solution of <strong>[55357-38-5]choline tosylate</strong> salt (86 g, 312 mmol) in MeCN (1.5 L) was added followed by a solution of triethylamine (20 ml) in dichloromethane (30 ml) and the mixture was stirred at RT for 12 h. The reaction mixture was then concentrated, redissolved in THF (2.5 L), filtered and hydrolyzed with 11 ml of concentrated aqueous HC1. Then the solution was dried with MgS04 and reacted with palmitoyl chloride (31 ml, 28 g, 102 mmol) in the presence of excess of triethylamine. The solution was filtered, evaporated, redissolved in dichloromethane, washed several times with MeOH/H2O, dried, evaporated and the residue was reacted with excess of tetrabutylammonium fluoride 1M solution in THF at 45C. After completion the solution was evaporated, the residue re-dissolved in dichloromethane, washed with MeOH/H2O, concentrated and precipitated in acetone. The crude sphingomyelin thus obtained was filtered and purified by column chromatography on Silica gel using CH2C12 : MeOH : H20 65: 25: 4 as eluent to yield 20 g (31% from the sphingoid starting material 2a) of sphingomyelin 5a as white solid. 1H NMR 300 MHz (8 ppm, CD30D) : 0.89 (t, 6H), 1.28 (bm, 44H), 1.37 (bm, 2H), 1.56 (bm, 2H), 2.015 (m, 2H), 2.17 (m, 2H), 3.21 (s, 9H), 3.62 (m, 2H), 3.90-4. 12 (m, 4H), 4.26 (m, 2H), 5.435 (dd, 1H), 5.69 (dt, 1H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; In dichloromethane; at 20℃; for 24h;Inert atmosphere; | To a flame-dried, N2 protected 50 mL flask, 18 muL POCl3 (0.19 mmol) and 1.5 mL DCM were added. Then 3 mL DCM with 27 muL Et3N (0.19 mmol) and 6 (0.16 mg, 0.14 mmol) were added to the flask drop-wise over 20 min. This mixture was stirred for 1 h at room temperature. After this, 0.2 mL pyridine (1.2 mmol) and 128 mg <strong>[55357-38-5]choline tosylate</strong> (0.223 mmol) were added. The reaction was allowed to stand for 24 h at room temperature. 0.2 ml water was added to quench the reaction. The reaction mixture was concentrated and then passed through a TMD-8 resin column using THF/H2O (9:1) as mobile phase. The resulting crude product was purified on a silica gel column using three mobile phases in a row (100 mL DCM/MeOH = 85:15, 200 mL MeOH and then 100 mL DCM/MeOH/H2O, 65:25:4). Product yield (from 5 to 1, two steps) was 42%. 1-O-hexadecyl-2-pentadenoyl-sn-glycerol-3-phosphocholine (1) has a Rf 0.35 (DCM/MeOH/H2O, 65:25:4), 1H NMR (400 MHz, CDCl3): ? 5.13 (quintet, 1H, CH), ? 4.36 (s, 2H, POCH2CH2N+), ? 3.98 (m, 2H, CH2CHCH2), ? 3.88 (s, 2H, POCH2CH2N+), ? 3.55 (m, 4H, CH2CHCH2, OCH2C15H31), ? 3.44 (s, 9H, N+(CH3)3), ? 2.32 (t, 2H, CH2COO), ? 1.60 (quintet, 2H,beta-CH2), ? 1.53 (quintet, 2H, beta-CH2), ? 1.26 (br, s, 48H, 24 × CH2), ? 0.887 (t, 6H, CH3 × 2), and HRMS via TOF ES MS+ 706.5803 m/z (MW = 706.0). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With pyridine; dicyclohexyl-carbodiimide; at 20℃; for 48h;Inert atmosphere; | General procedure: To a suspension of the monopyridinium salt of phosphonic acid (5a-g) (0,27 mmol), <strong>[55357-38-5]choline tosylate</strong> (147 mg, 0,53 mmol) in mixture of dry pyridine:CCl3CN (10 mL, 80:20 v/v) DCC (165 mg, 0,80 mmol) was added at room temperature and the reaction was stirred for 48 h under nitrogen. Then the solvent was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (eluent: CHCl3:MeOH:H2O 65:25:3 v/v/v). The spectral data of obtained compounds 6a-g are given below: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With pyridine; dicyclohexyl-carbodiimide; at 20℃; for 48h;Inert atmosphere; | General procedure: To a suspension of the monopyridinium salt of phosphonic acid (5a-g) (0,27 mmol), <strong>[55357-38-5]choline tosylate</strong> (147 mg, 0,53 mmol) in mixture of dry pyridine:CCl3CN (10 mL, 80:20 v/v) DCC (165 mg, 0,80 mmol) was added at room temperature and the reaction was stirred for 48 h under nitrogen. Then the solvent was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (eluent: CHCl3:MeOH:H2O 65:25:3 v/v/v). The spectral data of obtained compounds 6a-g are given below: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With pyridine; dicyclohexyl-carbodiimide; at 20℃; for 48h;Inert atmosphere; | General procedure: To a suspension of the monopyridinium salt of phosphonic acid (5a-g) (0,27 mmol), <strong>[55357-38-5]choline tosylate</strong> (147 mg, 0,53 mmol) in mixture of dry pyridine:CCl3CN (10 mL, 80:20 v/v) DCC (165 mg, 0,80 mmol) was added at room temperature and the reaction was stirred for 48 h under nitrogen. Then the solvent was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (eluent: CHCl3:MeOH:H2O 65:25:3 v/v/v). The spectral data of obtained compounds 6a-g are given below: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With pyridine; dicyclohexyl-carbodiimide; at 20℃; for 48h;Inert atmosphere; | General procedure: To a suspension of the monopyridinium salt of phosphonic acid (5a-g) (0,27 mmol), <strong>[55357-38-5]choline tosylate</strong> (147 mg, 0,53 mmol) in mixture of dry pyridine:CCl3CN (10 mL, 80:20 v/v) DCC (165 mg, 0,80 mmol) was added at room temperature and the reaction was stirred for 48 h under nitrogen. Then the solvent was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (eluent: CHCl3:MeOH:H2O 65:25:3 v/v/v). The spectral data of obtained compounds 6a-g are given below: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With pyridine; dicyclohexyl-carbodiimide; at 20℃; for 48h;Inert atmosphere; | General procedure: To a suspension of the monopyridinium salt of phosphonic acid (5a-g) (0,27 mmol), <strong>[55357-38-5]choline tosylate</strong> (147 mg, 0,53 mmol) in mixture of dry pyridine:CCl3CN (10 mL, 80:20 v/v) DCC (165 mg, 0,80 mmol) was added at room temperature and the reaction was stirred for 48 h under nitrogen. Then the solvent was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (eluent: CHCl3:MeOH:H2O 65:25:3 v/v/v). The spectral data of obtained compounds 6a-g are given below: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With pyridine; dicyclohexyl-carbodiimide; at 20℃; for 48h;Inert atmosphere; | General procedure: To a suspension of the monopyridinium salt of phosphonic acid (5a-g) (0,27 mmol), <strong>[55357-38-5]choline tosylate</strong> (147 mg, 0,53 mmol) in mixture of dry pyridine:CCl3CN (10 mL, 80:20 v/v) DCC (165 mg, 0,80 mmol) was added at room temperature and the reaction was stirred for 48 h under nitrogen. Then the solvent was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (eluent: CHCl3:MeOH:H2O 65:25:3 v/v/v). The spectral data of obtained compounds 6a-g are given below: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53.2% | The phosphorus oxychloride(0.17 g, 1.1 mmol),Triethylamine(0. 05 g, 5 mmol)Using chloroform(5 mL)Nitrogen,Water bath temperature of 10 C,1,2-dioleoylglycerol(0.62 g, 1 mmol) in chloroform(5 mL)Was added to the former reaction solution,After the reaction,The reaction was continued for 4 h,The choline pairToluenesulfonate(0. 54 g, 1.98 mmol) was dissolved with pyridine (0. 87 g, ll mmol)Was added to the former reaction solution,The reaction was continued for 30 min,The reaction was continued for 15 h,Add mass percent20% of the 10% potassium bicarbonate solution (mass percent refers to the mass of potassium hydrogen carbonate as a percentage of the total mass of the aqueous potassium hydrogencarbonate solution)Stirring lh,The organic layer was separated,The aqueous layer was washed twice with 15 mL of chloroform,The organic layers were combined,Drying,The crude product,(20: 10: 1 v / nu / nu) to give the product 1,2-dioleoylphosphatidylcholine, which was purified by column chromatography, eluting with chloroform-methanol-The yield was 0.42 g, and the yield was 53.2%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55.1% | The phosphorus oxychloride(0.17 g, 1.1 mmol),Triethylamine(0. 05 g, 5 mmol)Using chloroform(5 mL)Nitrogen,The temperature was lowered to 10 C.1, 2-dipalmitoyl glycerol(0. 56 g, l mmol)Using chloroform(5 mL)Was added to the former reaction solution,After the reaction,The reaction was continued for 4 h,A mixture of <strong>[55357-38-5]choline p-toluenesulfonate</strong>(0. 54 g, 1.98 mmol) was treated with pyridine(0. 87 g, ll mmol) was dissolved,Was added to the former reaction solution,The reaction was continued for 30 min,Continue to reaction 15h, adding 10% potassium bicarbonate solution 20mL,Stirring lh,The organic layer was separated,The aqueous layer was washed twice with 15 mL of chloroform,The organic layer was combined and dried by spin-drying to give crude product, which was purified by column chromatography and eluted with chloroform-methanol-water (20: 10: 1 / v / v) to give 1,2-dipalmitoylphosphatidylcholine. 396 g, yield 55.1%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54.5% | (0.17 g, 1.1 mmol) and triethylamine (0.05 g, 5 mmol) were dissolved in chloroform (5 mL), nitrogen gas was introduced and the temperature of the water bath was 10 C. 1,2-Distearoylglycerol (0.54 g, 1.98 mmol) was treated with pyridine (0.87 g, 1 mmol), dissolved in chloroform (5 mL), added to the previous reaction solution and reacted for 30 min after the dropwise addition and continued for 4 h. , 11mmol) dissolved, added to the previous reaction solution, continue the reaction 30min, continue the reaction 15h, 10% potassium bicarbonate solution 20mL, stirring 1h, separate the organic layer, the water layer with 15mL of chloroform washed twice, combined (20: 10: 1 v / v / v) to give l, 2-distearoylphosphatidylcholine in a yield of 0.43 g (yield: 50%) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55.5% | Will phosphorus oxychloride(0.17 g, 1. l mmol),Triethylamine (0. 05 g, 5 mmol)With chloroform(5 mL) was dissolved,Access to nitrogen,Water bath temperature of l0 C,1,2-bis lauryl glycerol(0. 46 g, 1 mmol) was dissolved in chloroform (5 mL) and added to the preceding reaction solution,After dripping for 30 min,Continue to respond 4h,Choline p-toluenesulfonate(0. 54 g, 1.98 mmol) was dissolved with pyridine (0. 87 g, 1 l mmol)Was added to the preceding reaction solution,Continue to respond for 30min,Continue to react for 15 h,Add 10% potassium bicarbonate solution 20mL,Stirring lh,Separate the organic layer,The aqueous layer was washed twice with 15 mL of chloroform,The organic layer was combined and dried to give the crude product, which was purified by column chromatography, trichloromethane-methanol-water (20: 10: 1 v / nu / nu) to give 1,2-distearoylphosphatidylcholine, · 344 g, yield 55.5% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
As shown in Fig. 28, commercially available Fmoc-Ser(tBu)-OH is reacted with Nu,Nu-diisopropylamino methoxy phosphonamidic chloride to afford (1). (1) is then reacted with <strong>[55357-38-5]choline tosylate</strong> followed by oxidation with mCPBA to afford (2). Next, the Fmoc group on (2) is removed with 20% cyclohexylamine in DCM and the free amine is coupled to docosahexaenoic acid to afford (3) and (4) respectively. Following this, the tBu ester group on (4) is deprotected under acidic condition to yield (5). In a parallel line, the Fmoc group on a commercially available l-O-DMT-6- N-Fmoc-2-hydroxymethylhexane support (6) is removed using a solution of 20% piperidine in dimethylformamide to produce (7). Finally, (5) and (7) are coupled in the presence of isobutyl chloroformate to yield the functionalized support (8). | ||
[0369] As shown in Fig. 13, commercially available Fmoc-Ser(tBu)-OH is reacted with N,N- diisopropylamino methoxy phosphonamidic chloride to afford (1). (1) is then reacted with <strong>[55357-38-5]choline tosylate</strong> followed by oxidation with mCPBA to afford (2). Next, the Fmoc group on (2) is removed with 20% cyclohexylamine in DCM and the free amine is coupled to docosahexaenoic acid to afford (3) and (4) respectively. Following this, the tBu ester group on (4) is deprotected under acidic condition to yield (5). In a parallel line, the Fmoc group on a commercially available l-0-DMT-6-N-Fmoc-2-hydroxymethylhexane support (6) is removed using a solution of 20% piperidine in dimethylformamide to produce (7). Finally, (5) and (7) are coupled in the presence of isobutyl chloroformate to yield the functionalized support (8). (0540) [0370] CPG 8 (6.00 g, 330 muiotaetaomicron, 1 equiv.) was first treated with 20% piperidine in dry DMF for 15 minutes. This procedure was repeated twice to ensure complete deprotection of the Fmoc group. The amine-bearing CPG 9 was filtered off and washed successively with DCM, ACN and ether and dried under vacuum. Then the CPG 9 was mixed with a mixture of DHA (0.65 g, 1.98 mmol, 6 equiv.), HATU (0.25 g, 0.66 mmol, 2 equiv.) and DIEA (449 mu, 2.64 mmol, 8 equiv.) in dry DMF (42 mL). The suspension was mixed on a rotary mixer for 24h. The CPG was then filtered off and washed with DCM, ACN and ether and dried under vacuum. The CPG was capped with 16% N-methylimidazole in THF (CAP A) and acetic anhydride:pyridine:THF (1 :2:2, v/v/v) (CAP B) (1 : 1, v/v) during 15 min and was washed with DCM, ACN and ether and dried under vacuum. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | Compound 5 (2.9 g, 5.39 mmol, 1 equiv.) was dried with dry toluene and dry ACN. Choline p-toluenesulfonate (1.63 g, 5.93 mmol, 1.1 equiv.) was dried with toluene and dissolved in dry ACN (46 mL). This mixture was added to compound 5 through a cannula. ETT (0.25 M in ACN) (21.6 mL, 5.39 mmol, 1 equiv.) was added slowly with a syringe. The mixture was stirred 2h at room temperature. After reaching completion, the reaction mixture was quenched with methanol. Meta- chloroperoxybenzoic acid (mCPBA) (1.86 g, 10.78 mmol, 2 equiv.) was added by portion to the mixture. After 30 min of stirring, the mixture was reduced under vacuum. The crude was then purified by column chromatography on silica gel using a gradient of MeOH in DCM (0-30%) as eluent, to afford 6 as a mixture of tetrazolium (major counter anion) and tosylate (less than 5%) salts (2.7 g, 3.69 mmol, yield 69%). [0284] FontWeight="Bold" FontSize="10" H NMR (400 MHz, CDC13) deltaEta (ppm) 7.72 (d, / = 7.6 Hz, 2H, Ar Fmoc) ; 7.66 (d, J = 8.0 Hz, 2H, Ar tosylate) ; 7.59 (d, / = 7.2 Hz, 2H, Ar Fmoc) ; 7.36 (t, / = 7.2 Hz, 2H, Ar Fmoc) ; 7.27 (t, / = 8.0 Hz, 2H, Ar Fmoc) ; 7.09 (d, / = 8.0 Hz, 2H, Ar tosylate) ; 6.80-6.70 (dd, / = 33.2 Hz, J = 7.2 Hz, 1H, NH) ; 4.51-4.36 (m, 6H, CH2 Fmoc + 2*CH2) ; 4.29-4.15 (m, 4H, CH2 CE + 2*CH) ; 3.83 (m, 2H, CH2) ; 3.25 (q, / = 7.2 Hz, 2H, CH2 tetrazolium) ; 3.19 (s, 9H, CH3) ; 2.72 (m, 2H, CH2 CE) ; 2.27 (s, 3H, CH3 tosylate) ; 1.44 (s, 9H, CH3 iBu) ; 1.18 (t, / = 7.2 Hz, 3H, CH3 tetrazolium). 13C NMR (100 MHz, CDC13) 5C (ppm) 167.77 (C=0) ; 163.89 (Cq tetrazolium) ; 156.16 (C=0) ; 143.69, 143.63, 141.11 (Cq Fmoc) ; 128.81, 125.63 (CH tosylate) ; 127.69, 127.07, 125.24, 125.17, 119.91 , (CH Ar Fmoc) ; 143.15, 139.73 (Cq tosylate) ; 117.18 (Cq CE) ; 83.22 (Cq iBu) ; 67.96 (CH2) ; 67.14 (CH2 Fmoc) ; 65.25 (CH2) ; 62.91 (CH2 CE) ; 61.88 (CH) ; 54.85 (CH2) ; 54.10 (CH3) ; 46.88 (CH Fmoc) ; 27.86 (CH3 iBu) ; 21.18 (CH3 tosylate) ; 19.58 (CH2 tetrazolium) ; 19.51 (CH2 CE) ; 6.80 (CH3 tetrazolium). 31P NMR (161 MHz, CDC13) deltaRho (ppm) - 2.60, -2.71. HRMS (ESI +) m/z for calculated C30H4iN3O8P (M+H) 603.2799 ; Found 603.2853. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | [0374] Compound 5 (2.9 g, 5.39 mmol, 1 equiv.) was dried with dry toluene and dry ACN. Choline p-toluenesulfonate (1.63 g, 5.93 mmol, 1.1 equiv.) was dried with toluene and dissolved in dry ACN (46 mL). This mixture was added to compound 5 through a cannula. ETT (0.25 M in ACN) (21.6 mL, 5.39 mmol, 1 equiv.) was added slowly with a syringe. The mixture was stirred 2h at room temperature. After reaching completion, the reaction mixture was quenched with methanol. Meta-chloroperoxybenzoic acid (mCPBA) (1.86 g, 10.78 mmol, 2 equiv.) was added by portion to the mixture. After 30 min of stirring, the mixture was reduced under vacuum. The crude was then purified by column chromatography on silica gel using a gradient of MeOH in DCM (0-30%) as eluent, to afford 6 as a mixture of tetrazolium (major counter anion) and tosylate (less than 5%) salts (2.7 g, 3.69 mmol, yield 69%). [0375] 1H NMR (400 MHz, CDC13) deltaEta (ppm) 7.72 (d, J = 7.6 Hz, 2H, Ar Fmoc) ; 7.66 (d, J = 8.0 Hz, 2H, Ar tosylate) ; 7.59 (d, J = 7.2 Hz, 2H, Ar Fmoc) ; 7.36 (t, J = 7.2 Hz, 2H, Ar Fmoc) ; 7.27 (t, J = 8.0 Hz, 2H, Ar Fmoc) ; 7.09 (d, J = 8.0 Hz, 2H, Ar tosylate) ; 6.80-6.70 (dd, J = 33.2 Hz, J = 7.2 Hz, 1H, NH) ; 4.51-4.36 (m, 6H, CH2 Fmoc + 2*CH2) ; 4.29-4.15 (m, 4H, CH2 CE + 2*CH) ; 3.83 (m, 2H, CH2) ; 3.25 (q, J = 7.2 Hz, 2H, CH2 tetrazolium) ; 3.19 (s, 9H, CH3) ; 2.72 (m, 2H, CH2 CE) ; 2.27 (s, 3H, CH3 tosylate) ; 1.44 (s, 9H, CH3 tBu) ; 1.18 (t, J = 7.2 Hz, 3H, CH3 tetrazolium). 13C NMR (100 MHz, CDC13) 5C (ppm) 167.77 (C=0) ; 163.89 (Cq tetrazolium) ; 156.16 (C=0) ; 143.69, 143.63, 141.11 (Cq Fmoc) ; 128.81, 125.63 (CH tosylate) ; 127.69, 127.07, 125.24, 125.17, 119.91, (CH Ar Fmoc) ; 143.15, 139.73 (Cq tosylate) ; 117.18 (Cq CE) ; 83.22 (Cq tBu) ; 67.96 (CH2) ; 67.14 (CH2 Fmoc) ; 65.25 (CH2) ; 62.91 (CH2 CE) ; 61.88 (CH) ; 54.85 (CH2) ; 54.10 (CH3) ; 46.88 (CH Fmoc) ; 27.86 (CH3 tBu) ; 21.18 (CH3 tosylate) ; 19.58 (CH2 tetrazolium) ; 19.51 (CH2 CE) ; 6.80 (CH3 tetrazolium). 31P NMR (161 MHz, CDC13) deltaRho (ppm) -2.60, -2.71. HRMS (ESI +) m/z for calculated C30H4iN3O8P (M+H) 603.2799 ; Found 603.2853. [0376] Note: The order of addition of reactants during the synthesis of 6 is important. If compound 5 and ETT are mixed prior to the addition of <strong>[55357-38-5]choline p-toluenesulfonate</strong> a side reaction will occur according to the Scheme S4. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5 ml (75 mmol) of glycidol was dissolved in 100 ml of chloroform.13 ml DIPEA was added and the mixture was cooled to 0C.7.0 ml (75 mmol) of phosphorus oxychloride was added dropwise at 0C.After that, the mixture was allowed to warm to room temperature.After stirring for 8h,Next, g (75 mmol) <strong>[55357-38-5]choline tosylate</strong> in 25 ml pyridine was added.The mixture was stirred overnight.Then 20 ml of water was slowly added and the mixture was stirred for a further 2 h.Most of the solvent was evaporated and the residue was mixed with 100 ml of water.After extraction with ethyl acetate, the combined organic layers were dried over sodium sulfate.Evaporation of the solvent produces glycidylphosphocholine. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | 3.06 g (20 mmol) of phosphorus oxychloride and 40 mL of dichloromethane were placed in an eggplant flask (300 mL), and the mixture was stirred at 0 C. 20 mL of a mixed dichloromethane solution of 292 mg (2 mmol) of diethylene glycol monoallyl ether and 158 mg (2 mmol) of pyridine was slowly added dropwise, and the mixture was stirred at 0 C. for 1 hour and at room temperature for 1 hour. Excess of phosphorus oxychloride and dichloromethane were distilled off and dried under reduced pressure. To the obtained crude phosphoric acid chloride was added 40 mL of pyridine, and the mixture was stirred at 0 C. 2.76 g (10 mmol) of Corinthsirat was added while thoroughly stirring, and the mixture was stirred at room temperature for 24 hours. Water (20 mL) was added to the reaction solution, and the mixture was further stirred at room temperature for 6 hours. Pyridine and water were distilled off, and the objective substance was purified by performing silica gel column (methanol: chloroform = 100: 100 ? 0) twice.Colorless liquidYield 50% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
34% | 3.06 g (20 mmol) of phosphorus oxychloride and 40 mL of dichloromethane were placed in an eggplant flask (300 mL), and the mixture was stirred at 0 C. 20 mL of a mixed dichloromethane solution of 200 mg (2 mmol) of 5-hexen-1-ol and 158 mg (2 mmol) of pyridine was slowly added dropwise and the mixture was stirred at 0 C. for 1 hour and at room temperature for 1 hour. Excess of phosphorus oxychloride and dichloromethane were distilled off and dried under reduced pressure. To the obtained crude phosphoric acid chloride was added 40 mL of pyridine, and the mixture was stirred at 0 C. 2.76 g (10 mmol) of Corinthsirat was added while thoroughly stirring, and the mixture was stirred at room temperature for 24 hours. Water (20 mL) was added to the reaction solution, and the mixture was further stirred at room temperature for 6 hours. Pyridine and water were distilled off, and the objective substance was purified by performing silica gel column (methanol: chloroform = 100: 100 ? 0) twice. Colorless solid Yield 34% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | 3.06 g (20 mmol) of phosphorus oxychloride and 40 mL of dichloromethane were placed in an eggplant flask (300 mL), and the mixture was stirred at 0 C. 20 mL of a mixed dichloromethane solution of 204 mg (2 mmol) of ethylene glycol monoallyl ether and 158 mg (2 mmol) of pyridine was slowly added dropwise, and the mixture was stirred at 0 C. for 1 hour and at room temperature for 1 hour. Excess of phosphorus oxychloride and dichloromethane were distilled off and dried under reduced pressure. To the obtained crude phosphoric acid chloride was added 40 mL of pyridine, and the mixture was stirred at 0 C. 2.76 g (10 mmol) of Corinthsirat was added while thoroughly stirring, and the mixture was stirred at room temperature for 24 hours. Water (20 mL) was added to the reaction solution, and the mixture was further stirred at room temperature for 6 hours. Pyridine and water were distilled off, and the objective substance was purified by performing silica gel column (methanol: chloroform = 100: 100 ? 0) twice.Colorless solidYield 65% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 1H-tetrazole; | The amino group of l-0-hexadecyl-2-deoxy-2-amino-s.n- glycerol (1) was protected with a tert-butyl (Boc) protect ing group by reaction with di- ert-butyl dicarbonate in the presence of triethylamine in dichloromethane (see Scheme 1) . The free 3-OH group of the resulting protected glycerol (2) derivative was then phosphytilated by reaction with bis (diisopropylamino) (2-cyanoethoxy) -phosphine in the pres ence of a diisopropylaminotetrazole as an activator in wa ter-free dichloromethane. The phosphytilated product (3) was isolated by flash chromatography on silica gel with a 84.8% yield. The following sequential reactions were per formed as one-pot reactions and monitored by TLC: 1) con densation with <strong>[55357-38-5]choline tosylate</strong> in the presence of te- trazole giving (4), 2) oxidation of phosphorus ( 111 ) to phosphorus (V) by tert-butylhydroperoxide to give (5) , and 3) cleavage of the 2-cyanoethyl protecting group at phos phorus by triethylamine to give (6) . After purification, 2- Boc-amino-3-phosphocholine (6) was obtained with 60.0% yield. The deprotection of the amino-group in (6) by tri- fluoracetic acid led to l-0-hexadecyl-2-deoxy-2-amino-s.n- glycero-3-phosphocholine (7), the "scaffold" compound, which was further used for syntheses of prostaglandin-like phospholipids . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | In a 100 ml round bottom flask, 3 g of compound IV was dissolved in 20 ml of chloroform.1.3 g of triethylamine and 3.5 g of <strong>[55357-38-5]p-toluenesulfonate choline</strong> were added.After reacting at 0 C for 8 h, it was returned to room temperature, 30 ml of 10% aqueous sodium hydrogencarbonate solution was added, and the reaction was continued at 20 C for 1 h.Liquid separation, an organic layer was dried and evaporated to dryness, crude product was slurried with acetonitrile, suction filtered to give a white waxy solid 2.8g, yield 87%. |
Tags: 55357-38-5 synthesis path| 55357-38-5 SDS| 55357-38-5 COA| 55357-38-5 purity| 55357-38-5 application| 55357-38-5 NMR| 55357-38-5 COA| 55357-38-5 structure
[ 68258-71-9 ]
1,1',1'',1'''-(Ethane-1,2-diylbis(azanetriyl))tetrakis(propan-2-ol) 4-methylbenzenesulfonate
Similarity: 0.85
[ 34985-57-4 ]
1,4-Diazabicyclo[2.2.2]octane 4-methylbenzenesulfonate
Similarity: 0.84
[ 14034-59-4 ]
Ethane-1,2-diamine 4-methylbenzenesulfonate
Similarity: 0.83
[ 123091-15-6 ]
2-(Dimethylamino)ethyl 4-methylbenzenesulfonate
Similarity: 0.82
[ 84461-21-2 ]
Propan-2-aminium 4-methylbenzenesulfonate
Similarity: 0.82
[ 68258-71-9 ]
1,1',1'',1'''-(Ethane-1,2-diylbis(azanetriyl))tetrakis(propan-2-ol) 4-methylbenzenesulfonate
Similarity: 0.85
[ 94249-11-3 ]
2-Hydroxy-N,N-bis(2-hydroxyethyl)-N-methyldodecan-1-aminium 4-methylbenzenesulfonate
Similarity: 0.81
[ 68258-71-9 ]
1,1',1'',1'''-(Ethane-1,2-diylbis(azanetriyl))tetrakis(propan-2-ol) 4-methylbenzenesulfonate
Similarity: 0.85
[ 14034-59-4 ]
Ethane-1,2-diamine 4-methylbenzenesulfonate
Similarity: 0.83
[ 123091-15-6 ]
2-(Dimethylamino)ethyl 4-methylbenzenesulfonate
Similarity: 0.82
[ 84461-21-2 ]
Propan-2-aminium 4-methylbenzenesulfonate
Similarity: 0.82
[ 14985-42-3 ]
N,N,N-Trimethyldodecan-1-aminium 4-methylbenzenesulfonate
Similarity: 0.81
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :